# Sodium Acetate Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 15 - Latest FDA row update: 08/15/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Fresenius Kabi USA, LLC — Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) — FDA availability: Available — updated: 08/04/2026 - Hikma Pharmaceuticals USA, Inc. — Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) — FDA availability: Available — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) — FDA availability: Available — updated: 08/07/2026 - Milla Pharmaceuticals — Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) — FDA availability: Available — updated: 08/15/2026 - Milla Pharmaceuticals — Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) — FDA availability: Available — updated: 08/15/2026 - Milla Pharmaceuticals — Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) — FDA availability: Available — updated: 08/15/2026 - Milla Pharmaceuticals — Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) — FDA availability: Limited Availability — updated: 08/15/2026 - Somerset Therapeutics, LLC — Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20) — FDA availability: Available — updated: 07/20/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/sodium-acetate-injection) - [JSON record](https://citefacts.com/shortages/sodium-acetate-injection.json)